Business Daily Media

Men's Weekly

.

Life Sciences on the Chinese Mainland – Vital signs: Diagnosing trends in the life sciences real estate market on the Chinese mainland

HONG KONG SAR - Media OutReach Newswire - 1 August 2025 - Cushman & Wakefield, a leading global real estate services firm, today released its Life Sciences on the Chinese Mainland Vital signs: Diagnosing trends in the life sciences real estate market on the Chinese mainland report.

It is based on in-depth interview surveys we conducted on professionals active in the life sciences sector on the Chinese mainland. The life sciences industry on the Chinese mainland is undergoing a transformative phase, driven by progressive policies, groundbreaking innovations, the emergence of influential life sciences companies, and strategic regional development. This report delves into the latest trends shaping the sector.

Policy Landscape National and Local Catalysts

Reforms enacted in 2024-2025 have significantly accelerated sector development. Nationally, China relaxed restrictions on foreign investment in gene and cell therapy and allowed the establishment of wholly foreign-owned hospitals in key cities. Regulatory incentives – such as data protection and marketing exclusivity – have improved market access for innovative drugs. Locally, cities like Beijing, Shanghai, Shenzhen, Guangzhou, and Suzhou are rolling out targeted subsidies, fast-track approvals, and ecosystem-building programmes that directly benefit biotech development.

Recent national policy initiatives on the Chinese mainland

Types of policies
Detail information
Opening to Foreign Investment
In 2024, China eased restrictions on foreign investments in stem cell research, gene therapy, and genetic diagnostics within Free Trade Zones (FTZs) like Beijing, Shanghai, Guangdong, and Hainan.
Regulatory Incentives
The State Council's Circular No. 53 introduced measures such as regulatory data protection and marketing exclusivity for select pharmaceutical products, including orphan and paediatric drugs.
Wholly Foreign-Owned Hospitals
China now permits the establishment of wholly foreign-owned hospitals in cities like Beijing, Shanghai, and Shenzhen, enhancing healthcare services and encouraging foreign investment.
Source: Cushman & Wakefield Research

Industry Innovation and Company Growth

Chinese life sciences companies are moving beyond generic drug manufacturing toward innovative therapies. Firms like Akeso, BeiGene, Gracell, and Legend Biotech are now global players, leading in CAR-T, bispecific antibodies, and AI-assisted R&D. These companies are not only commercialising cutting-edge treatments but also attracting international investment and licensing agreements, reinforcing the Chinese mainland's global relevance in life sciences.

Real Estate Development and Regional Hubs

Innovation hubs such as Suzhou BioBAY, Zhangjiang Hi-Tech Park (Shanghai), and the Bioisland Innovation Centre (Guangdong) are central to regional clustering. These hubs offer end-to-end support, including shared labs, venture capital access, GMP-compliant facilities, and proximity to academic and clinical networks. The rise of second-tier innovation cities like Chengdu and Ningbo further expands growth corridors.

The "R&D + Manufacturing + Service" ecosystem
Source: Cushman & Wakefield Research

Landlord Perspectives Evolving Real Estate Models

Real estate developers and landlords are adapting to sector-specific requirements through asset-light models, flexible leasing, and high-specification lab and production space. Tier-1 cities face saturation, but central and western regions exhibit healthy demand. Developers are incorporating advanced sustainability and compliance features to meet growing regulatory and ESG expectations, particularly in GMP and cleanroom environments.

Digitalisation, environmental policies, and differentiated tenant strategies are shaping performance. Operators now focus on integrated ecosystems with platforms that link tenants to R&D services, policy benefits, and technology partners.

Occupier Perspectives Growth, Innovation, and Challenges

Life sciences occupiers are navigating regulatory reform, rising compliance demands, and intensified market competition. Many are localising production and R&D, leveraging regional subsidies, and investing in AI-powered innovation platforms. Occupiers seek flexibility, proximity to talent and infrastructure, and co-located R&D and manufacturing to support accelerated innovation and operational agility.

In real estate, demand is strongest for GMP-certified labs, modular production facilities, and shared innovation platforms. Occupiers emphasise location advantages, sustainability certifications (e.g., LEED, WELL), and integration into clusters that enable faster time-to-market.

Tony Su, Managing Director, National Head of Industrial & Logistics Property Services, China, said, "Life sciences business parks on the Chinese mainland demonstrated clear regional differentiation, highlighting opportunities for strategic positioning. While Tier-1 cities saw more moderate performance due to broader macroeconomic factors and abundant supply, core cities in central and western regions recorded healthy occupancy rates, underpinned by strong industrial clustering and increasingly sophisticated ecosystems – contributing to steady growth in asset value."

Johnathan Wei, President, Project & Occupier Services, China, said, "Several interviewed life sciences companies on the Chinese mainland achieved revenue growth supported by innovative products and favourable policy tailwinds. While overall growth remained modest for many, a select group reported strong performance, highlighting opportunities for differentiation".

Andrew Chan, Managing Director, Head of Valuation & Advisory Services, Greater China, said," Looking ahead to 2025 and beyond, growth opportunities lie in AI-driven drug discovery, personalised medicine, advanced therapeutics (CGT, RNA), and green-certified facilities. Government policies continue to support innovation through fast-track approvals, rare disease funding, and subsidies aligned with dual-carbon and ESG goals".

Shaun Brodie, Head of Research Content, Greater China, "Life sciences real estate is shifting from generic parks to specialised, digitally enabled campuses with high compliance and flexibility. Investment strategies increasingly emphasise long-term partnerships, collaborative operating models, and digital infrastructure. Both landlords and occupiers express cautious optimism, with strategic differentiation and regional targeting seen as keys to unlocking future value".

Please click here to download the full report.


Hashtag: #Cushman&Wakefield

The issuer is solely responsible for the content of this announcement.

About Cushman & Wakefield

Cushman & Wakefield (NYSE: CWK) is a leading global commercial real estate services firm for property owners and occupiers with approximately 52,000 employees in nearly 400 offices and 60 countries. In Greater China, a network of 23 offices serves local markets across the region. In 2024, the firm reported revenue of $9.4 billion across its core services of Valuation, Consulting, Project & Development Services, Capital Markets, Project & Occupier Services, Industrial & Logistics, Retail, and others. Built around the belief that Better never settles, the firm receives numerous industry and business accolades for its award-winning culture. For additional information, visit or follow us on LinkedIn ().

News from Asia

ICONSIAM Showcases Thai Creativity to the World with "Lost in DOMLAND" — Reinforcing Its Role as a Must-Visit Global Art Destination

The first-ever full-scale solo exhibition by Udom Taephanich, sets a new milestone for Thai contemporary art on the global stage.BANGKOK, THAILAND - Media OutReach Newswire - 11 July 2025 - ICONSI...

MyRepublic Awarded #1 Best Fixed Network in Asia by Ookla®

SINGAPORE - Media OutReach Newswire - 30 July 2025 - MyRepublic announces that it has been officially recognised by Ookla®, a global leader in connectivity intelligence, as the #1 Best Fixed Netw...

Apical Advances EUDR Readiness Ahead of Full Regulatory Implementation

SINGAPORE - Media OutReach Newswire - 30 July 2025 - Apical has successfully implemented a robust management system to ensure full compliance with the European Union's Deforestation Regulation (EU...

YBUOJ Responds to BaFin Announcement, Reaffirms Compliance Credentials and Global Regulatory Commitment

COLORADO, USA - Media OutReach Newswire - 28 July 2025 - YBUOJ has issued an official response to a recent notice from the Federal Financial Supervisory Authority of Germany (BaFin), which alleged...

Regional Regulatory Misunderstanding, YBUOJ Responds Proactively to BaFin Advisory

COLORADO, USA - Media OutReach Newswire - 29 July 2025 - The Federal Financial Supervisory Authority of Germany (BaFin) recently issued a public advisory stating that crypto exchange YBUOJ was off...

SIBUR Develops New Grade of Polypropylene for Hygiene Products

MOSCOW, RUSSIA - Media OutReach Newswire - 30 July 2025 - SIBUR, Russia's largest polymer producer, has developed a new grade of polypropylene designed for use in hygiene and medical products...

SIBUR Begins Installation of Polypropylene Production Line at Amur GСC

MOSCOW, RUSSIA - Media OutReach Newswire - 30 July 2025 - SIBUR, Russia's largest polymer producer, has started installing a polypropylene production unit at the Amur Gas Chemical Complex (GСC), w...

Shenzhen and Hong Kong Join Hands to Promote the Development of the Hetao Shenzhen-Hong Kong Science & Technology Innovation Co-operation Zone

"Driving the Globalization of Clinical Trials in the Guangdong-Hong Kong-Macao Greater Bay Area, Implementing the First Key Cross-Border Multi-Center Clinical Trial Project"HONG KONG SAR - Media O...

Pacific Century Premium Developments Limited announces interim results for six months ended June 30, 2025

2025 Interim Results - Financial Highlights (Figures for the corresponding period in 2024 are shown in brackets) Consolidated revenue: HK$ 736 million (HK$ 545 million) Consolid...

V-GREEN and GSM Philippines sign strategic partnership with MERALCO to promote EV infrastructure development in the Philippines

MANILA, PHILIPPINES - Media OutReach Newswire - 30 July 2025 - V-Green Global Charging Station Development Corporation (V-Green) and Green and Smart Mobility Joint Stock Company (Green GSM Philipp...

Small-Business Cash-Flow Playbook 2025

An educational guide to managing ATO debt, real-time super and growth finance in Australia’s new landscape Why ATO debt just became the most expe...

Landowners Offered $30,000 Per Year for Just 1 Hectare: The Rise of 5MW Battery Projects Across Australia

In a pivotal shift reshaping Australia’s renewable energy landscape, landowners in Queensland, New South Wales, and Victoria are being offered up ...

Major national security tech alliance launches with Aerologix a founding member

Australia’s leading drone intelligence pioneer bolsters sovereign tech power Australia’s leading aerial data and drone intelligence platform, Aer...

Chris Hancock AM Honoured as 2025 Communications Ambassador

SYDNEY Chris Hancock AM, former CEO of AARNet, has been awarded the prestigious Communications Ambassador title at the 2025 Telecommunications Indus...

Baby boomers are driving development feasibility leading to larger apartments

As residential developers continue to grapple with feasibility issues on apartment projects, the sector is struggling to deliver volumes of new st...

Hays launches FY25/26 Salary Guide: ‘Salary Paradox’ deepens as pay rises fail Australians

Rising dissatisfaction with pay, progression and perks is fuelling a new wave of career change in FY25/26, as Australians demand more from employe...

Sell by LayBy